The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Westlake Chemical's revenues will contract -15.9% and EPS will wane -4.6%.
The average estimate for revenue is $870.1 million. On the bottom line, the average EPS estimate is $1.25.
Last quarter, Westlake Chemical tallied revenue of $801.0 million. GAAP reported sales were 6.8% lower than the prior-year quarter's $859.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.42. GAAP EPS of $1.41 for Q4 were 262% higher than the prior-year quarter's $0.39 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 23.8%, much better than the prior-year quarter. Operating margin was 19.4%, much better than the prior-year quarter. Net margin was 11.9%, 880 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $3.70 billion. The average EPS estimate is $6.36.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 101 members out of 113 rating the stock outperform, and 12 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 25 give Westlake Chemical a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Westlake Chemical is hold, with an average price target of $69.88.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Westlake Chemical to My Watchlist.